Using Machine Learning to Predict the Risk of Either Having an Aggressive Form of Prostate Cancer (PCa) or Lower Grade PCa/Benign Prostatic Hyperplasia (BPH) Based Upon the Flow Cytometry Immunophenotyping of Myeloid-derived Suppressor Cells (MDSCs) and Lymphocyte Cell Populations

Presentation

Combining Immunophenotyping and Artificial Intelligence for Early Cancer Detection

Presentation

Combining the Immunophenotyping of MDSCs and Lymphocytes with Artificial Intelligence (AI) to Predict Early Stage Breast Cancer

Poster

Sign up for email Updates

Be The First to Receive Breaking News

Sign Up Now
Logo Itus

Latest News & Events

Anixa Biosciences to Present at the Sachs Associates 5th Annual Immuno-Oncology BD&L and Investment Forum

Read More...

Anixa Biosciences Announces Completion of Cchek™ Analytical Verification at CLIA Laboratory

Read More...

Anixa Biosciences to Present at B. Riley FBR Institutional Investor Conference

Read More...

Cancer of the Lung, Breast, Colon, Prostate, and Stomach are the five most prevalent cancers worldwide.